A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease

NCT01526785 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

113

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to approved label expansion

Conditions

Pompe Disease

Interventions

DRUG: Alglucosidase alfa

Sponsor

Genzyme, a Sanofi Company